Arcturus Therapeutics

Arcturus Therapeutics

Biotechnology
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.

$221M

Market Cap • 11/13/2025

2008

(17 years)

Founded

2013

(12 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country